Published in Reg Anesth Pain Med on July 21, 2006
Upper extremity regional anesthesia: essentials of our current understanding, 2008. Reg Anesth Pain Med (2009) 2.47
Fatty-acid oxidation and calcium homeostasis are involved in the rescue of bupivacaine-induced cardiotoxicity by lipid emulsion in rats. Crit Care Med (2012) 1.93
Resuscitation with lipid emulsion: dose-dependent recovery from cardiac pharmacotoxicity requires a cardiotonic effect. Anesthesiology (2014) 1.53
Lipid emulsion infusion: resuscitation for local anesthetic and other drug overdose. Anesthesiology (2012) 1.51
Intravenous lipid emulsion in clinical toxicology. Scand J Trauma Resusc Emerg Med (2010) 1.39
Intralipid infusion ameliorates propranolol-induced hypotension in rabbits. J Med Toxicol (2008) 1.06
Intravenous lipid emulsion for local anesthetic toxicity: a review of the literature. J Med Toxicol (2008) 1.06
Vasoconstriction potency induced by aminoamide local anesthetics correlates with lipid solubility. J Biomed Biotechnol (2012) 1.00
Lipid emulsion for local anesthetic systemic toxicity. Anesthesiol Res Pract (2011) 0.97
Immediate lipid emulsion therapy in the successful treatment of bupivacaine systemic toxicity. Reg Anesth Pain Med (2009) 0.95
Lipid emulsion-mediated reversal of toxic-dose aminoamide local anesthetic-induced vasodilation in isolated rat aorta. Korean J Anesthesiol (2013) 0.95
Multi-modal contributions to detoxification of acute pharmacotoxicity by a triglyceride micro-emulsion. J Control Release (2014) 0.91
Use of Intralipid in an infant with impending cardiovascular collapse due to local anesthetic toxicity. J Anesth (2009) 0.85
Lipid emulsions enhance the norepinephrine-mediated reversal of local anesthetic-induced vasodilation at toxic doses. Yonsei Med J (2013) 0.82
Evaluating the effects and safety of intravenous lipid emulsion on haloperidol-induced neurotoxicity in rabbit. Biomed Res Int (2014) 0.79
Insulin Signaling in Bupivacaine-induced Cardiac Toxicity: Sensitization during Recovery and Potentiation by Lipid Emulsion. Anesthesiology (2016) 0.79
A review of local anesthetic cardiotoxicity and treatment with lipid emulsion. Local Reg Anesth (2010) 0.76
Clonidine in resuscitation of bupivacaine-related cardiac arrest. Reg Anesth Pain Med (2007) 0.75
Lipid rescue for bupivacaine toxicity during cardiovascular procedures. Heart Int (2010) 0.75
Cardiac depression induced by cocaine or cocaethylene is alleviated by lipid emulsion more effectively than by sulfobutylether-β-cyclodextrin. Acad Emerg Med (2015) 0.75
Local anesthetic systemic toxicity (LAST) - Should we not be concerned? Med J Armed Forces India (2012) 0.75
Measurement of the efficacy of 2% lipid in reversing bupivacaine- induced asystole in isolated rat hearts. BMC Anesthesiol (2014) 0.75
Differential effects of short- and long-term bupivacaine treatment on α1-adrenoceptor-mediated contraction of isolated rat aorta rings and the reversal effect of lipid emulsion. Acta Pharmacol Sin (2015) 0.75
Should we consider the infusion of lipid emulsion in the resuscitation of poisoned patients? Crit Care (2014) 0.75
Lidocaine-Induced Systemic Toxicity: A Case Report and Review of Literature. Cureus (2017) 0.75
The possible role of intravenous lipid emulsion in the treatment of chemical warfare agent poisoning. Toxicol Rep (2016) 0.75
Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity. Reg Anesth Pain Med (2003) 3.87
Lipid emulsion is superior to vasopressin in a rodent model of resuscitation from toxin-induced cardiac arrest. Crit Care Med (2009) 3.56
Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. Genet Med (2011) 3.21
Rapid cardiotonic effects of lipid emulsion infusion*. Crit Care Med (2013) 2.76
Epinephrine impairs lipid resuscitation from bupivacaine overdose: a threshold effect. Anesthesiology (2009) 2.11
Cell signaling and the genesis of neuropathic pain. Sci STKE (2004) 2.06
Canadian guidelines for training in adult perioperative transesophageal echocardiography. Recommendations of the Cardiovascular Section of the Canadian Anesthesiologists' Society and the Canadian Society of Echocardiography. Can J Anaesth (2006) 1.97
Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J Neurochem (2007) 1.61
Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci (2011) 1.60
Resuscitation with lipid emulsion: dose-dependent recovery from cardiac pharmacotoxicity requires a cardiotonic effect. Anesthesiology (2014) 1.53
Postoperative troponin-T predicts prolonged intensive care unit length of stay following cardiac surgery. Crit Care Med (2004) 1.53
Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain (2011) 1.50
Noradrenergic depletion potentiates beta -amyloid-induced cortical inflammation: implications for Alzheimer's disease. J Neurosci (2002) 1.46
Preventive analgesia by local anesthetics: the reduction of postoperative pain by peripheral nerve blocks and intravenous drugs. Anesth Analg (2013) 1.45
Enhanced interpretation of newborn screening results without analyte cutoff values. Genet Med (2012) 1.44
The effect of bupivacaine on myocardial tissue hypoxia and acidosis during ventricular fibrillation. Anesth Analg (2004) 1.41
The OHRP and SUPPORT--another view. N Engl J Med (2013) 1.38
A role for Hox A5 in regulating angiogenesis and vascular patterning. Lymphat Res Biol (2005) 1.33
Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis. J Neuroimmunol (2005) 1.29
Resuscitation with lipid versus epinephrine in a rat model of bupivacaine overdose. Anesthesiology (2008) 1.28
Endothelin receptors and pain. J Pain (2009) 1.27
Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline. J Neurosci (2009) 1.22
A novel fluorescent probe that is brain permeable and selectively binds to myelin. J Histochem Cytochem (2006) 1.19
The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1. ASN Neuro (2011) 1.19
A novel interaction of Cap-binding protein complexes eukaryotic initiation factor (eIF) 4F and eIF(iso)4F with a region in the 3'-untranslated region of satellite tobacco necrosis virus. J Biol Chem (2004) 1.19
Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes. J Biol Chem (2002) 1.18
Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1. Pain (2011) 1.14
Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment. Mol Pharmacol (2006) 1.14
Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet. Ann Neurol (2003) 1.13
P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis. J Neuroinflammation (2008) 1.12
Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease. Neurobiol Aging (2006) 1.11
The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS. Brain Pathol (2002) 1.10
Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of anti-inflammatory properties. J Neurochem (2005) 1.10
Methamphetamine causes persistent immune dysregulation: a cross-species, translational report. Neurotox Res (2010) 1.09
Clinical experience using intranasal ketamine in the treatment of pediatric bipolar disorder/fear of harm phenotype. J Affect Disord (2012) 1.08
Synthesis and characterization of deoxynivalenol glucuronide: its comparative immunotoxicity with deoxynivalenol. Food Chem Toxicol (2007) 1.08
Aortic valve replacement surgery: comparison of outcomes in matched sternotomy and PORT ACCESS groups. Ann Thorac Surg (2010) 1.07
A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women. Am J Clin Nutr (2005) 1.05
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes. J Neuroinflammation (2011) 1.05
The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. J Neurochem (2006) 1.04
Anti-inflammatory and antiproliferative actions of PPAR-gamma agonists on T lymphocytes derived from MS patients. J Leukoc Biol (2003) 1.04
Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta production. J Neuroinflammation (2004) 1.03
Focused ultrasound effects on nerve action potential in vitro. Ultrasound Med Biol (2009) 1.03
The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease. Neurobiol Aging (2011) 1.03
Endothelin-1 (ET-1) selectively enhances the activation gating of slowly inactivating tetrodotoxin-resistant sodium currents in rat sensory neurons: a mechanism for the pain-inducing actions of ET-1. J Neurosci (2002) 1.02
mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis. Glia (2012) 1.02
Effect of pioglitazone treatment in a patient with secondary multiple sclerosis. J Neuroinflammation (2004) 1.00
A PPARdelta agonist reduces amyloid burden and brain inflammation in a transgenic mouse model of Alzheimer's disease. Curr Alzheimer Res (2009) 0.99
Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta. J Neurochem (2007) 0.98
Identification of light-independent inhibition of human immunodeficiency virus-1 infection through bioguided fractionation of Hypericum perforatum. Virol J (2009) 0.97
Effect of pioglitazone treatment on behavioral symptoms in autistic children. J Neuroinflammation (2007) 0.95
Norepinephrine protects cortical neurons against microglial-induced cell death. J Neurosci Res (2005) 0.94
Discounting of delayed rewards and executive dysfunction in individuals infected with hepatitis C. J Clin Exp Neuropsychol (2010) 0.93
A pilot study of the Copper T380A IUD and oral levonorgestrel for emergency contraception. Contraception (2010) 0.93
Increasing CNS noradrenaline reduces EAE severity. J Neuroimmune Pharmacol (2009) 0.93
Changing end-of-life care practice for liver transplant service patients: structured palliative care intervention in the surgical intensive care unit. J Pain Symptom Manage (2012) 0.93
Extended medial gastrocnemius rotational flap for treatment of chronic knee extensor mechanism deficiency in patients with and without total knee arthroplasty. Clin Orthop Relat Res (2004) 0.92
The role of the glia limitans in ADP-induced pial arteriolar relaxation in intact and ovariectomized female rats. Am J Physiol Heart Circ Physiol (2004) 0.92
Effects of lovastatin and pravastatin on amyloid processing and inflammatory response in TgCRND8 brain. Neurochem Res (2004) 0.92
Partitioning effect in lipid resuscitation: further evidence for the lipid sink. Crit Care Med (2010) 0.92
The value of pharmacists in health care. Popul Health Manag (2012) 0.92
A pilot test of pioglitazone as an add-on in patients with relapsing remitting multiple sclerosis. J Neuroimmunol (2009) 0.91
Epinephrine induces rapid deterioration in pulmonary oxygen exchange in intact, anesthetized rats: a flow and pulmonary capillary pressure-dependent phenomenon. Anesthesiology (2012) 0.91
Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation: evidence-based clinical science should guide FDA decision making about product labeling. Contraception (2006) 0.91
Modulation of inducible nitric oxide synthase expression by sumoylation. J Neuroinflammation (2009) 0.91
Improved antiretroviral refill adherence in HIV-focused community pharmacies. J Am Pharm Assoc (2003) (2012) 0.90
Noradrenergic depletion increases inflammatory responses in brain: effects on IkappaB and HSP70 expression. J Neurochem (2003) 0.90
An absorbable local anesthetic matrix provides several days of functional sciatic nerve blockade. Anesth Analg (2009) 0.90
Estrogen inhibits NF kappa B-dependent inflammation in brain endothelium without interfering with I kappa B degradation. Neuroreport (2002) 0.89
Medication adherence for 90-day quantities of medication dispensed through retail and mail order pharmacies. Am J Manag Care (2011) 0.89
Intrinsic regulation of brain inflammatory responses. Cell Mol Neurobiol (2003) 0.88
Safety of high volume lipid emulsion infusion: a first approximation of LD50 in rats. Reg Anesth Pain Med (2010) 0.88
Nociceptive sensitization by endothelin-1. Brain Res Rev (2008) 0.86
Prolonged suppression of postincisional pain by a slow-release formulation of lidocaine. Anesthesiology (2011) 0.86
Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576. Neuropharmacology (2005) 0.86
15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway. J Neurochem (2006) 0.86
Frequency domain near-infrared spectroscopy technique in the assessment of brain oxygenation: a validation study in live subjects and cadavers. J Neurosci Methods (2006) 0.86
The relationship between functional sciatic nerve block duration and the rate of release of lidocaine from a controlled-release matrix. Anesth Analg (2010) 0.85
Norepinephrine increases I kappa B alpha expression in astrocytes. J Biol Chem (2002) 0.85
Effects of pioglitazone on diffusion tensor imaging indices in multiple sclerosis patients. Neurosci Lett (2010) 0.84
Effects of noradrenaline on neuronal NOS2 expression and viability. Antioxid Redox Signal (2006) 0.84
Dual Roles for Endothelin-B Receptors in Modulating Adjuvant-Induced Inflammatory Hyperalgesia in Rats. Open Pain J (2009) 0.83
Sildenafil (Viagra) ameliorates clinical symptoms and neuropathology in a mouse model of multiple sclerosis. Acta Neuropathol (2011) 0.83
Beta-amyloid-dependent expression of NOS2 in neurons: prevention by an alpha2-adrenergic antagonist. Antioxid Redox Signal (2006) 0.83
Regulation of MCP-1 production in brain by stress and noradrenaline-modulating drugs. J Neurochem (2010) 0.83
Inhibition of lentivirus replication by aqueous extracts of Prunella vulgaris. Virol J (2009) 0.83
Effect of anti-inflammatory agents on transforming growth factor beta over-expressing mouse brains: a model revised. J Neuroinflammation (2004) 0.83
Five year outcomes study of dental rehabilitation conducted under general anesthesia for special needs patients. Anesth Prog (2007) 0.82
Agminated, eruptive pyogenic granuloma-like lesions developing over congenital vascular stains. Pediatr Dermatol (2011) 0.82
Endothelin-1 raises excitability and reduces potassium currents in sensory neurons. Brain Res Bull (2009) 0.82
Early and late contributions of glutamate and CGRP to mechanical sensitization by endothelin-1. J Pain (2009) 0.82